Insmed Incorporated
INSM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $142 | $107 | $93 | $104 |
| % Growth | 32.5% | 15.7% | -11.1% | – |
| Cost of Goods Sold | $59 | $28 | $21 | $26 |
| Gross Profit | $84 | $79 | $72 | $78 |
| % Margin | 58.7% | 73.9% | 77.1% | 75% |
| R&D Expenses | $186 | $177 | $153 | $180 |
| G&A Expenses | $0 | $155 | $148 | $143 |
| SG&A Expenses | $186 | $155 | $148 | $143 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $136 | $60 | $20 | -$14 |
| Operating Expenses | $508 | $392 | $320 | $309 |
| Operating Income | -$425 | -$313 | -$248 | -$230 |
| % Margin | -298.4% | -291.3% | -267.3% | -220.6% |
| Other Income/Exp. Net | $56 | -$8 | -$8 | -$4 |
| Pre-Tax Income | -$369 | -$320 | -$256 | -$234 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | -$370 | -$322 | -$257 | -$236 |
| % Margin | -260% | -299.5% | -276.4% | -225.5% |
| EPS | -1.75 | -1.7 | -1.42 | -1.32 |
| % Growth | -2.9% | -19.7% | -7.6% | – |
| EPS Diluted | -1.75 | -1.7 | -1.42 | -1.32 |
| Weighted Avg Shares Out | 212 | 189 | 181 | 179 |
| Weighted Avg Shares Out Dil | 211 | 189 | 181 | 179 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18 | $13 | $14 | $17 |
| Interest Expense | $20 | $21 | $22 | $22 |
| Depreciation & Amortization | $4 | $4 | $3 | $3 |
| EBITDA | -$344 | -$297 | -$233 | -$212 |
| % Margin | -241.9% | -276.6% | -250.8% | -202.7% |